# Cryodevitalization for the Treatment of Early Stage Lung Cancer, CRYSTAL Trial

> **NCT06593106** · NA · RECRUITING · sponsor: **Vanderbilt-Ingram Cancer Center** · enrollment: 30 (estimated)

## Conditions studied

- Stage I Lung Cancer
- Stage II Lung Cancer

## Interventions

- **PROCEDURE:** Cryosurgery
- **PROCEDURE:** Robotic Bronchoscopy
- **PROCEDURE:** Bronchoscopy with Biopsy
- **PROCEDURE:** Resection
- **PROCEDURE:** Chest Radiography
- **PROCEDURE:** Computed Tomography
- **PROCEDURE:** Biospecimen Collection
- **OTHER:** Electronic Health Record Review

## Key facts

- **NCT ID:** NCT06593106
- **Lead sponsor:** Vanderbilt-Ingram Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-09-27
- **Primary completion:** 2026-07-30
- **Final completion:** 2026-08-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-02-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06593106

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06593106, "Cryodevitalization for the Treatment of Early Stage Lung Cancer, CRYSTAL Trial". Retrieved via AI Analytics 2026-08-08 from https://api.ai-analytics.org/clinical/NCT06593106. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*